- Home
- ARWR vs WAL Comparison
ARWR vs WAL Comparison
Compare ARWR & WAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARWR | WAL |
|---|---|---|
| Founded | 2003 | 1994 |
| Country | United States | United States |
| Employees | N/A | 3524 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1B | 9.6B |
| IPO Year | 2009 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARWR | WAL |
|---|---|---|
| Price | $64.60 | $81.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 15 |
| Target Price | $81.50 | ★ $101.40 |
| AVG Volume (30 Days) | ★ 2.7M | 1.3M |
| Earning Date | 05-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.09% |
| EPS Growth | ★ 99.80 | N/A |
| EPS | ★ 0.22 | N/A |
| Revenue | ★ $16,142,321.00 | N/A |
| Revenue This Year | N/A | $20.16 |
| Revenue Next Year | N/A | $8.63 |
| P/E Ratio | $287.41 | ★ $10.88 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.66 | $57.05 |
| 52 Week High | $76.76 | $97.23 |
Technical Indicators
Market Signals| Indicator | ARWR | WAL |
|---|---|---|
| Relative Strength Index (RSI) | 51.54 | 35.69 |
| Support Level | $60.53 | $70.53 |
| Resistance Level | $65.59 | $87.53 |
| Average True Range (ATR) | 2.68 | 3.84 |
| MACD | 0.01 | -1.49 |
| Stochastic Oscillator | 87.05 | 20.72 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About WAL Western Alliance Bancorporation (DE)
Western Alliance Bancorp provides a full spectrum of customized loan, deposit, and treasury management capabilities, including funds transfer and other digital payment offerings. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.